ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
11 Dec 2018 ESMO Immuno-Oncology Congress Showcases New Technologies Set to Improve Cancer Treatment [ESMO Press Release] Cancer Immunology and Immunotherapy
11 Dec 2018 Death Rates from Cancer will Fall in Australasian Countries and Russia in 2018: Researchers Call for Urgent Measures on Tobacco control, Especially in Russia [Annals of Oncology Press Release]
29 Nov 2018 ESMO Immuno-Oncology Congress: Where the Community of Stakeholders Meets [ESMO Media Alert] Cancer Immunology and Immunotherapy
21 Nov 2018 Rare Cancers Asia: Building Bridges to Improve Patient Care [ESMO Press Release] Personalised medicine
20 Nov 2018 Misconceptions about Opioids Affect Pain Control Among Cancer Patients: a Malaysian Survey [ESMO Asia 2018 Press Release] Palliative and supportive care - Bioethics, legal and economic issues - Personalised medicine
13 Nov 2018 2018 ESMO Immuno-Oncology Award goes to Cornelis Melief [ESMO Press Release] Cancer Immunology and Immunotherapy
06 Nov 2018 ESMO Asia 2018 Congress [ESMO Media Alert]
22 Oct 2018 Patients with HPV-positive oropharynx cancer should receive chemoradiation [ESMO 2018 Press Release] Head and neck cancers - Cancer Immunology and Immunotherapy
22 Oct 2018 Immunotherapy improves survival in metastatic or recurrent head and neck cancer [ESMO 2018 Press Release] Head and neck cancers - Cancer Immunology and Immunotherapy
22 Oct 2018 Major response to immunotherapy in early-stage mismatch repair deficient colon cancer [ESMO 2018 Press Release] Gastrointestinal cancers - Cancer Immunology and Immunotherapy
22 Oct 2018 Immunotherapy may become new first line treatment in some metastatic colorectal cancers [ESMO 2018 Press Release] Gastrointestinal cancers
21 Oct 2018 Local radiotherapy improves survival in metastatic prostate cancer with low disease burden [ESMO 2018 Press Release] Genitourinary cancers
21 Oct 2018 Olaparib maintenance extends progression-free survival by estimated 3 years in advanced ovarian cancer [ESMO 2018 Press Release] Gynaecologic malignancies
21 Oct 2018 Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma [ESMO 2018 Press Release] Genitourinary cancers
21 Oct 2018 Erlotinib improves progression-free survival in early mutated non-small cell lung cancer [ESMO 2018 Press Release] Lung and other thoracic tumours